Aktie GW PHARMACEUTICALS PLC
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren
Inaktiver Wert

Andere Sprachen GW Pharmaceuticals plc London S.E.

Aktien

GB0030544687

Schlusskurs London S.E.
Andere Börsenplätze
- GBX - Intraday Chart für GW Pharmaceuticals plc
2021 Tochtergesellschaft von Jazz Pharmaceuticals erhält britische Zulassung für Epidyolex bei Patienten mit Anfällen im Zusammenhang mit tuberöser Sklerose Complex MT
2021 HINTERGRUND/Bei Pharma-Übernahmen schlagen inzwischen oft Midcaps zu DJ

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Fitch Affirms Jazz's IDR at 'BB-'; Outlook Positive
Former President of GW Pharmaceuticals USA Joins Lexaria Bioscience as Strategic Advisor
Jazz Pharmaceuticals Announces Significant New Investment in UK Manufacturing
JAZZ PHARMACEUTICALS ANNOUNCES FULL YEAR AND FOURTH QUARTER 2021 FINANCIAL RESULTS
Jazz Pharmaceuticals : U.S. FDA approves expanded use of Jazz Pharma's sleep disorder drug Xywav
Sector Update: Health Care Stocks Steady Premarket Tuesday
Jazz Pharmaceuticals : GW Pharmaceuticals Bags UK Nod for New Use of Cannabis-Based Seizure Drug
Jazz Pharmaceuticals' : Subsidiary Gets UK Approval for Epidyolex in Patients With Tuberous Sclerosis Complex-Related Seizures
Gw Pharmaceuticals Receives Approval for Epidyolex (Cannabidiol) from the MHRA for the Treatment of Seizures Associated with Tuberous Sclerosis Complex
Jazz Pharmaceuticals : Updates 2021 Full-Year Guidance Following GW Pharmaceuticals Buy
Jazz Pharmaceuticals : Updates FY2021 Outlook to Reflect GW Pharmaceuticals Purchase
Palla Pharma : Names New CEO; Shares Soar 18%
Alkame : PAO Group, Inc.'s CBD Nutraceuticals Expected To Deliver Revenue-Generating Catalyst in 2021; New Partnerships Expand Its Long-Term CBD Pharmaceutical Programs
GW Pharmaceuticals plc(NasdaqGM:GWPH) dropped from S&P Global BMI Index
PAO Group, With A CRO On Its Side, Could Deliver Its First CBD-Based Therapeutic By Year's End
GW PHARMACEUTICALS PLC : Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Other Events, Financial Statements and Exhibits (form 8-K)
Jazz Pharmaceuticals : Completes Purchase of GW Pharmaceuticals
GW Pharmaceuticals : Jazz Pharmaceuticals Completes Acquisition of GW Pharmaceuticals plc
GW Pharmaceuticals plc(NasdaqGM:GWPH) dropped from NASDAQ Composite Index
Jazz Pharmaceuticals plc completed the acquisition of GW Pharmaceuticals plc.
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A1T980 Aktie
  4. Aktie
  5. Nachrichten GW Pharmaceuticals plc
  6. Andere Sprachen